Financials

  • Market Capitalization 1.75 B
  • Employee 104
  • Founded 2019
  • CEO N/A
  • Website firsttracksbio.com
  • Headquarter Delaware, United States
  • FIGI BBG020RF4QV8
  • Industry N/A

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
1985
COAG
Hemab Therapeutics Holdings, Inc. Common Stock
39.29 USD-1.43%-5.33%+11.62%+45.52%1.84 B USD
1988
BRVE
Braveheart Bio, Inc. Common Stock
20.3900 USD+5.81%+1.75%-3.55%-32.48%1.83 B USD
2042
KRSA
Korsana Biosciences, Inc. Common Stock
37.56 USD+5.95%+18.11%+17.38%+53.81%1.71 B USD
2078
HAPN
Happen, Inc. Common Stock
14.11 USD-4.86%-8.61%-2.89%-27.27%1.63 B USD

Frequently asked questions about First Tracks Biotherapeutics, Inc. Ordinary Shares

What is the First Tracks Biotherapeutics, Inc. Ordinary Shares stock price today?

The current price of First Tracks Biotherapeutics, Inc. Ordinary Shares (TRAX) is 41.64. Over the past 24 hours, the stock has changed by -6.34%. Follow the TRAX chart for real-time price dynamics.

What is the stock ticker of First Tracks Biotherapeutics, Inc. Ordinary Shares?

First Tracks Biotherapeutics, Inc. Ordinary Shares trades under the ticker TRAX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is First Tracks Biotherapeutics, Inc. Ordinary Shares stock going up?

TRAX has changed by -10.49% over the last week, -1.49% over the last month, and +103.02% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of First Tracks Biotherapeutics, Inc. Ordinary Shares?

First Tracks Biotherapeutics, Inc. Ordinary Shares currently has a market capitalization of 1.75 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were First Tracks Biotherapeutics, Inc. Ordinary Shares earnings last quarter?

Last quarter, First Tracks Biotherapeutics, Inc. Ordinary Shares reported earnings of -0.88 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was First Tracks Biotherapeutics, Inc. Ordinary Shares net income for the last quarter?

First Tracks Biotherapeutics, Inc. Ordinary Shares reported net income of -31.36 M for the last quarter. The previous quarter showed -33.37 M, which means net income changed by +6.05%.

How many employees does First Tracks Biotherapeutics, Inc. Ordinary Shares have?

As of the latest available data, First Tracks Biotherapeutics, Inc. Ordinary Shares has 104 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy First Tracks Biotherapeutics, Inc. Ordinary Shares stock?

You can buy First Tracks Biotherapeutics, Inc. Ordinary Shares (TRAX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in First Tracks Biotherapeutics, Inc. Ordinary Shares stock?

Investing in First Tracks Biotherapeutics, Inc. Ordinary Shares requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the TRAX chart and related analysis on metatrader.com as part of your research.